employed gene therapy to restore auditory function in individuals with congenital DFNB9 resulting from OTOF mutations (NCT05901480 and ChiCTR2200063181).[14, 15, 16]. Here, OTOF is linked to autosomal recessive nonsyndromic hearing loss 9.